Christopher M. Lindblom, See Remarks at INFINITY PHARMACEUTICALS, INC. (INFI), sold 13,885 shares at $25.73 ($357K) on 2012-11-26, disclosed to the SEC on 2012-11-27.
Open-market sale of $357k INFI by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.